Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Kurin, Inc. v. Magnolia Medical Technologies, Inc.
Case Number:
3:18-cv-01060
Court:
Nature of Suit:
Judge:
Firms
-
July 20, 2020
Blood Testing Device Co. Notches Win In Rival's False Ad Suit
Blood testing device maker Magnolia Medical Technologies Inc. scored a win on Monday in a suit by a rival alleging Magnolia falsely advertised its device as effective and approved by the U.S. Food and Drug Administration, with a California federal judge finding that its advertising claims are largely supported by medical studies.
-
May 30, 2018
Blood Test Co. Says Rival Falsely Advertised FDA Status
Kurin Inc. accused a competitor in the market for reducing false positives in blood tests of inaccurately advertising its device as if it were approved by the U.S. Food and Drug Administration and overstating its effectiveness, according to a suit filed Tuesday in California federal court.